BLU9931 |
Covalent inhibitor of FGFR4
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| FGFR4 |
|
Covalent inhibitor
50 - 500 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - FGFR1: 591 nM, FGFR2: 493 nM, FGFR3: 150 nM
Potency Assay Off-Target:
In kinome-wide selectivity panel containing 456 kinases (Kinomescan, DiscoveRx), BLU9931 bound signi ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
In FGFR1-driven cells (DMS114), BLU9931 had minimal activity.
Potency Cellular
In Vitro
FGFR4
Mode of Action: Covalent inhibitor
Structure-Activity-Relationship data available? No
In Vivo Validations
Female Balb/c nude mouse
Dose: 10, 30 and 100 mg/kg
Route of delivery:
Intravenous, Oral
Plasma half life:
2.3 h (oral, 10 mg/kg)
Organ of interest (O):
Hep 3B xenograft
Target engagement assay:
Indirect, assessment of CYP7A1 biomarker confirmed modulation of FGFR4.
Reference: --
Orthogonal Probes def
Roblitinib
Chemical Information
| Molecular Formula | C26H22Cl2N4O3 |
| SMILEs | C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1 |
| InChI | InChI=1S/C26H22Cl2N4O3/c1-5-21(33)30-18-8-6-7-14(2)25(18)32-26-29-13-16-11-15(9-10-17(16)31-26)22-23(27)19(34-3)12-20(35-4)24(22)28/h5-13H,1H2,2-4H3,(H,30,33)(H,29,31,32) |
| Molecular weight | 508.11 Da |
| AlogP | 0.0 |
| HBond acceptors | 7 |
| HBond donors | 2 |
| Atoms | 57 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.